Claritas Pharmaceuticals Inc V.CLAS.H

Weird, first they blame the TSX for all the BS, now they are

[Dude51]

blaming CMAX for all there338718338718* woes. Man what a bunch shysters, imo.

Claritas is focused on completing the phase 1 study as quickly as possible. Due to the inability of CMAX Clinical Research to provide an assurance that the phase 1 study will be completed during Q1 2022, Claritas has terminated its agreement with CMAX, and has entered into a clinical trial research agreement with Scientia Clinical Research, a state-of-the-art clinical trials facility with a focus on first-in-human and first-in-patient clinical studies located in Sydney, Australia. Scientia possesses world-class clinical trial expertise and conducts a wide range of clinical trials, with a focus on early stage clinical research. Scientia will use best efforts to complete the phase 1 study during Q1 2022.